A Review of Factors That Influence Individual Compliance with Mass Drug Administration for Elimination of Lymphatic Filariasis

被引:182
作者
Krentel, Alison [1 ,2 ]
Fischer, Peter U. [1 ]
Weil, Gary J. [1 ]
机构
[1] Washington Univ, Sch Med, Dept Internal Med, Div Infect Dis, St Louis, MO 63110 USA
[2] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England
来源
PLOS NEGLECTED TROPICAL DISEASES | 2013年 / 7卷 / 11期
基金
比尔及梅琳达.盖茨基金会;
关键词
NEGLECTED TROPICAL DISEASES; RURAL-AREAS; WESTERN PROVINCE; ORISSA STATE; TAMIL-NADU; PROGRAM; INDIA; COMMUNITY; IMPACT; COVERAGE;
D O I
10.1371/journal.pntd.0002447
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: The success of programs to eliminate lymphatic filariasis (LF) depends in large part on their ability to achieve and sustain high levels of compliance with mass drug administration (MDA). This paper reports results from a comprehensive review of factors that affect compliance with MDA. Methodology/Principal Findings: Papers published between 2000 and 2012 were considered, and 79 publications were included in the final dataset for analysis after two rounds of selection. While results varied in different settings, some common features were associated with successful programs and with compliance by individuals. Training and motivation of drug distributors is critically important, because these people directly interact with target populations, and their actions can affect MDA compliance decisions by families and individuals. Other important programmatic issues include thorough preparation of personnel, supplies, and logistics for implementation and preparation of the population for MDA. Demographic factors (age, sex, income level, and area of residence) are often associated with compliance by individuals, but compliance decisions are also affected by perceptions of the potential benefits of participation versus the risk of adverse events. Trust and information can sometimes offset fear of the unknown. While no single formula can ensure success MDA in all settings, five key ingredients were identified: engender trust, tailor programs to local conditions, take actions to minimize the impact of adverse events, promote the broader benefits of the MDA program, and directly address the issue of systematic non-compliance, which harms communities by prolonging their exposure to LF. Conclusions/Significance: This review has identified factors that promote coverage and compliance with MDA for LF elimination across countries. This information may be helpful for explaining results that do not meet expectations and for developing remedies for ailing MDA programs. Our review has also identified gaps in understanding and suggested priority areas for further research.
引用
收藏
页数:12
相关论文
共 88 条
  • [1] Factors associated with the acceptance of mass drug administration for the elimination of lymphatic filariasis in Agusan del Sur, Philippines
    Amarillo, Maria Lourdes E.
    Belizario, Vicente Y., Jr.
    Sadiang-abay, Jewel T.
    Sison, Stephanie Anne M.
    Dayag, Ariane Marie S.
    [J]. PARASITES & VECTORS, 2008, 1 (1)
  • [2] [Anonymous], 2011, MON EP ASS MASS DRUG
  • [3] [Anonymous], 2013, PROMISES PROGRESS 1
  • [4] [Anonymous], 1997, WHA501997REC1
  • [5] Anthony G, 2009, AM J TROP MED HYG, V81, P327
  • [6] Mass drug administration against filariasis in India: perceptions and practices in a rural community in Kerala
    Aswathy, S.
    Beteena, K.
    Leelamoni, K.
    [J]. ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY, 2009, 103 (07): : 617 - 624
  • [7] Coverage, compliance and some operational issues of mass drug administration during the programme to eliminate lymphatic filariasis in Orissa, India
    Babu, B
    Kar, SK
    [J]. TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2004, 9 (06) : 702 - 709
  • [8] Use of an inclusive-partnership strategy in urban areas of Orissa, India, to increase compliance in a mass drug administration for the control of lymphatic filariasis
    Babu, B. V.
    Behera, D. K.
    Kerketta, A. S.
    Mishra, S.
    Rath, K.
    Swain, B. K.
    Mishra, S.
    Kar, S. K.
    [J]. ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY, 2006, 100 (07): : 621 - 630
  • [9] A qualitative study on the adverse reactions of mass treatment for lymphatic filariasis in Orissa, India
    Babu, B., V
    [J]. ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE, 2010, 3 (01) : 55 - 58
  • [10] Mass drug administration under the programme to eliminate lymphatic filariasis in Orissa, India: a mixed-methods study to identify factors associated with compliance and non-compliance
    Babu, Bontha V.
    Mishra, Suchismita
    [J]. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2008, 102 (12) : 1207 - 1213